CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

2020 AHA/ACC Key Data Elements and Definitions for Coronary Revascularization A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Coronary Revascularization) Clopidogrel or ticagrelor in acute coronary syndrome patients treated with newer-generation drug-eluting stents: CHANGE DAPT Incidence, Predictors, and Outcomes of In-Hospital Percutaneous Coronary Intervention Following Coronary Artery Bypass Grafting SGLT2 Inhibitors in Patients With Heart Failure With Reduced Ejection Fraction: A Meta-Analysis of the EMPEROR-Reduced and DAPA-HF Trials Outcomes after drug-coated balloon treatment for patients with calcified coronary lesions Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic: From the ACC’s Interventional Council and SCAI Classification of Deaths in Cardiovascular Outcomes Trials Known Unknowns and Unknown Unknowns Contemporary use of drug-coated balloons in coronary artery disease: Where are we now? Treatment of Very Small De Novo Coronary Artery Disease With 2.0 mm Drug-Coated Balloons Showed 1-Year Clinical Outcome Comparable With 2.0 mm Drug-Eluting Stents Randomized comparison of stent strut coverage following angiography- or optical coherence tomography-guided percutaneous coronary intervention

Volume 75, Issue 16, April 2020

JOURNAL:JACC Article Link

2020 AHA/ACC Key Data Elements and Definitions for Coronary Revascularization A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Coronary Revascularization)

GJ Dehmer, V Badhwar, EA Bermude et al. Keywords: ACC/AHA Clinical Data Standards; ACS; CHD; PCI; CABG; coronary revascularization; clinical trials

Full Text PDF